Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hamburg Seeks To Rebuild FDA After Years Of Insufficient Resources

This article was originally published in The Gray Sheet

Executive Summary

FDA needs more funding to make up for years of neglect, Commissioner Margaret Hamburg said Feb. 8 at the AcademyHealth National Health Policy in Washington, D.C

You may also be interested in...



Foreign Manufacturing Cost-Savings Might Be Offset By Regulatory Due Diligence, FDA's Woodcock Cautions

Companies may have more work down the line dealing with regulatory authorities if they manufacture products in foreign countries not following an accepted regulatory structure.

Obama Budget Request Would Fund National Device Registry At FDA

The Obama administration's fiscal year 2011 budget request includes $4 million for a new medical device registry that would link unique device identifiers to electronic health data. The registry would be designed and built by FDA

Regulatory News In Brief

PREDICT at borders: FDA hopes to have its new border inspection tool, Predictive Risk-Based Evaluation for Dynamic Import Compliance Targeting, up and running nationwide by spring, Commissioner Margaret Hamburg said Feb. 4. The IT system considers various characteristics to pinpoint shipments in need of more comprehensive inspection and items that are less risky. It has been piloted for food inspections since 2007 and more recently for device and drug shipments (1"The Gray Sheet" Oct. 19, 2009)

Related Content

Topics

UsernamePublicRestriction

Register

MT028494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel